|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's Range||94.13 - 95.58|
|52 Week Range||77.64 - 110.15|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||1.18|
|Expense Ratio (net)||0.60%|
Index mutual funds and exchange-traded funds are natural lenders of stocks and bonds because they offer a broad and stable inventory of securities. Securities lending income isn't all gravy--it carries some risk. All told, we believe the benefits of securities lending to fundholders outweigh the risks.
Insys Therapeutics (INSY) is among the specialty pharmaceutical companies that focus on developing cannabinoids and sprays.
Insys Therapeutics’ (INSY) product pipeline includes cannabidiol oral solution and dronabinol inhalation. It also includes naloxone and epinephrine nasal sprays, buprenorphine and naloxone spray, and buprenorphine sublingual spray.
Among domestic equities, small-caps have been the place to be this year. The iShares Russell 2000 ETF (NYSARCA:IWM), the largest exchange-traded fund (ETF) dedicated to smaller domestic stocks, is up nearly 9% year-to-date while the large-cap S&P 500 is higher by just 1.8%.
Small-cap stocks and related small-cap ETFs are on a torrid pace this year, but investors looking for even more exciting gains with ETFs tracking small companies may want to consider the iShares Micro-Cap ...
Smaller stocks and corresponding exchange traded funds have recently been enjoying renewed fanfare and rightfully so. Year-to-date, the iShares Russell 2000 ETF (NYSE: IWM) is up 9.6 percent, or double the gains of the large-cap S&P 500. Smaller small-caps, or micro-caps, are performing even better.
Shares of microcap stocks have surged to record highs, far outpacing the broader market, and that may be a bearish signal. According to Maley, since 2007 there have been six previous instances when the iShares Microcap ETF ( IWC) outperformed the S&P 500 Index (SPX) over the course of several months. The iShares Microcap ETF had an all-time record high close on June 6, up 12% year-to-date.
The Nasdaq Composite, on the other hand, reached its upside objective of 7600 in January and has been consolidating below that level ever since. Was that the move, and now we reverse from this key extension target? Or should we instead focus on the fact that the Nasdaq just went out at an all-time monthly closing high, which is a characteristic of an uptrend, not a downtrend?
As the greenback soars to its highest levels of the year, one trader sees a couple of market areas that could ride the currency's coattails. "I will caution one thing" on the IWM, said Cappelleri. The U.S. dollar index has not traded above 94 since December 2017.